Exam 2: Acute Heart Failure Flashcards
ADHF CO
2-4
ADHF CI
1.3-2.0
PCWP ADHF
18-30
ADHF SVR
1500-3000
Maintaining Chronic Therapy While Hospitalized
continues meds unless pt becomes hemodynamically unstable or goes into shock
Beta Blockers
do not stop unless recent initiation or up-titration in current decompensation
hold if dobutamine is needed or hemodynamically unstable
digoxin
avoid d/c unless compelling reason
Warm and Dry
optimize chronic therapy
Warm and wet
iv diuretics and iv venous vasoilator
cold and dry
PWCP ≥ 15: IV inotrope
PCWP < 15: IV fluids until PCWP is 15-18
cold and wet
IV diuretics +
SBP<90: iv inotrope
SBP>90: iv arterial vasodilator
Loops
exceed chronic daily dose given as intermittent bolus
increase dose to ceiling
add oral MTZ (2.5) HCTZ (12.5) CTZ (250)
Vasodilator
used in combo with diuretics to reduce pulmonary congestion
II and IV HF
reduce preload
patients with symptomatic hypotension should not recieve vasodilators
considered over inotropes
Nitroprusside clinical effects
balanced vasodilator
decreased SVR
nitroprusside use
HTN crisis
nitroprusside aes
cyanide and thiocynate toxicity
nitroglycerin clinical effects
venous > arterial VD
decreased PCWP
nitroglycerin use of adhf
ACS, HTN crisis
warm and wet
nitroglycerin AEs
hypotension
headache
reflex tach
nitrate intolerance
nesiritide (natrecor)
balanced vasodilation
dobutamine MOA
positive inotropes
stimulates AC to increase cAMP
consider if low bp
Milrinone MOA
inodilator
PDE inhibitor increases cAMP in myocardium (increases CO) and vaseculture (dec SVR)
Milrinone clinical effects
venous >arterial vasodilator
consider if on a bet blocker
Milrinone brand name
primacor
use of inotropes
cold ad wet (IV)
cold and dry (if PCWP >15)
Use of Dopamine in ADHF
typically plays secondary role to dobutamine/milrinone
referred to as a vasopressor
choice of dobutamine vs milrinone is individualized
high svr
beta blocker use
when to use positive inotorpe therpay
COld